兽医葡萄球菌β-内酰胺折点性能评估:单药与苯唑西林替代标志物的比较分析
本研究基于美国与加拿大兽医诊断实验室的1914株假中间葡萄球菌临床分离株,比较苯唑西林检测mecA介导耐药及作为β-内酰胺类替代标志物的性能。结果显示苯唑西林预测mecA耐药敏感性最高,其他β-内酰胺类对mecA耐药菌的敏感率低且与苯唑西林相比有高比例极重大误差,支持将苯唑西林作为替代标志物并需澄清CLSI VET01S指南。
要点
- 苯唑西林是检测假中间葡萄球菌mecA介导耐药敏感性最高的药物。
- 其他β-内酰胺类对mecA阳性菌的耐药比例低(16.5%–85%),易误报敏感。
- 除头孢维星外,其他β-内酰胺类与苯唑西林相比极重大误差率高。
核心结论
- 苯唑西林是预测假中间葡萄球菌mecA介导β-内酰胺耐药的最敏感药物。
- 单独检测其他β-内酰胺类并据此报告存在误报敏感的重大风险。
- 支持将苯唑西林(及头孢西丁)作为β-内酰胺类药敏的替代标志物。
研究设计与样本
- 研究纳入美国与加拿大兽医诊断实验室的假中间葡萄球菌临床分离株n=1,914。
- 采用肉汤微量稀释法检测阿莫西林-克拉维酸、头孢唑林、头孢维星、头孢泊肟、头孢噻吩和苯唑西林的MIC。
- 同时检测mecA存在与否,并进行一致性分析、敏感性和特异性计算。
主要发现
- 苯唑西林在所有分析药物中预测mecA介导耐药的敏感性最高。
- 对携带mecA的分离株,除苯唑西林外其他β-内酰胺类显示耐药MIC的比例在16.5%至85%之间。
- 与苯唑西林相比,除头孢维星外所有β-内酰胺类均呈现高比例极重大误差。
关键数值与推荐
- 对携带mecA的分离株,除苯唑西林外其他β-内酰胺类耐药MIC比例为16.5%–85%。
临床怎么用
- 应使用苯唑西林和头孢西丁作为葡萄球菌β-内酰胺类药敏的替代标志物。
- 避免仅依据单个β-内酰胺类药物检测结果报告敏感,以减少误报。
- 需参考CLSI VET01S澄清后的标准进行兽医葡萄球菌药敏解释。
局限性
- 研究仅针对假中间葡萄球菌,未涵盖其他兽医葡萄球菌种。
- 原文未报告具体特异性数值及极重大误差的具体比例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Staphylococcus pseudintermedius is an important pathogen in companion animals. Accurate detection and reporting of mecA-mediated resistance to β-lactam antimicrobials is essential for guiding appropriate antimicrobial treatments. While surrogate agents are used in human diagnostic laboratories to predict β-lactam results in staphylococci, individual β-lactam breakpoints are published for veterinary staphylococci, discouraging the use of a surrogate. Comparative performance of these individual β-lactam breakpoints to predict methicillin-resistance in veterinary Staphylococcus species has not been previously evaluated. This study evaluated oxacillin's accuracy at detecting mecA presence and performance as a surrogate for β-lactams in S. pseudintermedius from canids and felids. Antimicrobial susceptibility data for S. pseudintermedius were obtained from clinical isolates (n = 1,914) from veterinary diagnostic laboratories across the United States and Canada and included broth microdilution results for amoxicillin-clavulanate, cefazolin, cefovecin, cefpodoxime, cephalothin, and oxacillin, along with the corresponding presence or absence of mecA. Agreement analysis, sensitivities, and specificities were calculated to compare oxacillin performance with individual β-lactams. Oxacillin demonstrated the highest sensitivity for the prediction of mecA-mediated resistance among all antimicrobials analyzed. For isolates possessing mecA, the proportion showing resistant minimum inhibitory concentrations to β-lactams other than oxacillin was low, ranging between 16.5% and 85%. Additionally, when compared to oxacillin, all β-lactams other than cefovecin exhibited high rates of very major discrepancies, corroborating the significant risk of reporting false susceptibility when testing these antimicrobials. These findings support utilizing oxacillin as a surrogate agent for predicting β-lactam interpretations and emphasize the necessity for clarified guidance in the Clinical Laboratory Standards Institute VET01S document.IMPORTANCEAccurate testing and reporting of β-lactam antimicrobials in Staphylococcus species are essential for guiding appropriate antimicrobial therapy in companion animals. Our findings show that oxacillin is the most sensitive antimicrobial for detecting mecA-mediated resistance when testing Staphylococcus pseudintermedius, while most other β-lactams have low sensitivity for mecA and unacceptable rates of very major discrepancies when compared to oxacillin. These results highlight the risk of reporting falsely reporting β-lactam results when interpretations are based solely on testing each individual agent. Therefore, oxacillin and cefoxitin should be used as surrogate markers for β-lactam susceptibility, as appropriate for the Staphylococcus species, to minimize the risk of reporting false susceptible results. The clarification of these criteria by the Clinical and Laboratory Standards Institute in VET01S will enhance diagnostic accuracy, aid effective antimicrobial stewardship, and improve clinical outcomes in veterinary medicine.
引用
- Gefroh SJ, Meier BM, Bowden RR, et al. Evaluating veterinary Staphylococcus β-lactam breakpoint performance: a comparative analysis of individual agents versus oxacillin as a surrogate. J Clin Microbiol. 2026. PMID: 42283514. doi:10.1128/jcm.00168-26
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。